May 2016 FDA Recall Drug by Akorn, Inc.
D-0949-2016 - Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability

This Class II drug recall was voluntarily initiated by Akorn, Inc. on May 17, 2016 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility; some lots failed antimicrobial effectiveness testing on stability. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0949-2016

Reason for Recall
Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability
Initiated
05-17-2016
Reported
06-08-2016
Quantity
57,920 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide and Puerto Rico.
Sulfacetamide Sodium Ophthalmic Solution, USP, 10%, Sterile, Rx Only, 15 mL bottles, Mfd. by: Akorn, Inc., Lake Forest, IL 60045 --- NDC 17478-221-12

Batch or Lot Expiration Information

Lot# 5A17A, Expiry 06/16
Lot# 5K21A, Expiry 03/17
Lot# 6A08A, Expiry 06/17